REZORSTOBART
UNII Q3SE2QPZ2H

Substance Identification & Data

This profile provides standardized clinical and technical data for Rezorstobart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Q3SE2QPZ2H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2762201-86-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Q3SE2QPZ2H

CAS Registry Number

2762201-86-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

REZORSTOBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199611

National Cancer Institute reference terminology for clinical and research data.

INN ID

12766

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Rezorstobart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

REZORSTOBART

Common Names & Synonyms

IMMUNOGLOBULIN G1 (301-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN CD161 ANTIGEN) (HUMAN MONOCLONAL IMT-009 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMT-009 .KAPPA.-CHAIN, DIMER

REZORSTOBART [INN]